Although antidepressant-associated dyskinesia has been previously reported, this side effect has not been documented for fluoxetine, a selective inhibitor of presynaptic re-uptake of serotonin. Because of its clinical importance and its contribution to the understanding of the psychopharmacology of dyskinesia, such a case is described. The dyskinesia associated with antidepressants and also with fluoxetine appears to differ from that of neuroleptics. Antidepressants including fluoxetine may exacerbate rather than cause the pathophysiological process involved in the dyskinesia.
|Original language||English (US)|
|Number of pages||4|
|Journal||Neuropsychiatry, Neuropsychology and Behavioral Neurology|
|State||Published - Apr 1992|
ASJC Scopus subject areas
- Clinical Neurology
- Psychiatry and Mental health